Open, single centre, pilot study to investigate a steroid free immunosuppressive regimen for de novo renal transplant recipients followed by randomisation to calcineurin inhibitor containing or calcineurin inhibitor free immunosuppression

Trial Profile

Open, single centre, pilot study to investigate a steroid free immunosuppressive regimen for de novo renal transplant recipients followed by randomisation to calcineurin inhibitor containing or calcineurin inhibitor free immunosuppression

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2012

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Sirolimus (Primary) ; Tacrolimus (Primary) ; Basiliximab; Methylprednisolone
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Jun 2010 Actual patient number (100) added as reported by ClinicalTrials.gov.
    • 29 Jun 2010 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
    • 29 Jun 2010 Status changed from recruiting to completed added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top